4.1 Article

Severe COVID-19-Induced Hemophagocytic Lymphohistiocytosis

Related references

Note: Only part of the references are listed.
Review Rheumatology

Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic

Mehmet Soy et al.

Summary: Hemophagocytic syndrome (HPS) or hemophagocytic lymphohistiocytosis (HLH) is an acute systemic inflammatory disorder characterized by excessive cytokine production and hyperferritinemia. It can be primary, caused by genetic mutations, or secondary, triggered by underlying disorders like malignancies or infections. In COVID-19 patients, secondary HLH and cytokine storm may lead to severe symptoms such as progressive fever, cytopenia, ARDS, and organ failure. Early differentiation and classification are crucial for appropriate treatment strategies.

RHEUMATOLOGY INTERNATIONAL (2021)

Review Rheumatology

Haemophagocytic syndrome and COVID-19

Soledad Retamozo et al.

Summary: HLH is a hyperferritinaemic hyperinflammatory syndrome characterized by decreased interferon gamma production and activated NK phenotype. Viruses are closely linked to the development of HLH, and the break of tolerance to self-antigens is considered a critical mechanism in immune-mediated conditions triggered by viral infections.

CLINICAL RHEUMATOLOGY (2021)

Review Medicine, General & Internal

Secondary Hemophagocytic Lymphohistiocytosis and Autoimmune Cytopenias: Case Description and Review of the Literature

Bruno Fattizzo et al.

Summary: HLH is a rare hyperinflammatory condition that can be difficult to diagnose and life-threatening. Patients may present with acute cytopenias, but differential diagnosis with other diseases such as AIC and lymphoproliferative disorders is necessary.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Secondary Hemophagocytic Lymphohistiocytosis in Post-COVID-19 Patients: A Report of Two Cases

Pranjal Kalita et al.

Summary: HLH can affect both children and adults, categorized as primary or secondary. Post-COVID-19 patients who have recovered may present with sHLH due to dysregulation of the immune system.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Article Hematology

COVID-19 and its implications for thrombosis and anticoagulation

Jean M. Connors et al.

BLOOD (2020)

Article Cardiac & Cardiovascular Systems

Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19

Huihui Ren et al.

CARDIOVASCULAR DIABETOLOGY (2020)

Letter Virology

Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab

Austin R. Morrison et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Medicine, General & Internal

Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19

Hideta Nakamura et al.

INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Hemophagocytic lymphohistiocytosis associated with viral infections: Diagnostic challenges and therapeutic dilemmas

J. L. Mostaza-Fernandez et al.

REVISTA CLINICA ESPANOLA (2014)

Review Rheumatology

Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment

Claire Larroche

JOINT BONE SPINE (2012)

Article Hematology

How I treat hemophagocytic lymphohistiocytosis

Michael B. Jordan et al.

BLOOD (2011)

Review Oncology

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

Jan-Inge Henter et al.

PEDIATRIC BLOOD & CANCER (2007)